Neuropsychopharmacology: A Tribute to Joseph T. Coyle

This new volume from Advances in Pharmacology presents reviews of recent breakthroughs in glutamate pharmacology and a tribute to one of the most influential neuroscientists of our times. Features chapters from the best authors in the field. An essential resource for pharmacologists, immunologists, and biochemists alike.

Robert Schwarcz (Volume editor)

9780128097458, Elsevier Science

Hardback, published 8 June 2016

414 pages
22.9 x 15.1 x 2.7 cm, 0.84 kg

Praise for the Series:
"...recommended not only to pharmacologists but also to all those in related disciplines" --Nature

Neuropsychopharmacology: A Tribute to Joseph T. Coyle is a new volume from Advances in Pharmacology presenting reviews of recent breakthroughs in glutamate pharmacology and a tribute to one of the most influential neuroscientists of our times. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists, and biochemists alike.

Preface
Robert Schwarcz and S.J. Enna
Foreword
Solomon H. Snyder
1. My Life in Clinical Neuroscience: The Beginning
Joseph T Coyle
2. Kynurenines and Glutamate: Multiple Links and Therapeutic Implications
Robert Schwarcz
3. The Therapeutic Role of D-Cycloserine in Schizophrenia
Donald Goff
4. Impulsivity, Stimulant Abuse and Dopamine Receptor Signaling
Edythe D. London
5. Excitotoxicity as a Common Mechanism for Fetal Neuronal Injury with Hypoxia and Intrauterine Inflammation
Irina Burd, Jared Welling, Gokul Kannan, Michael V. Johnston
6. Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors
Zila Martinez-Lozada, Alain M. Guillem and Michael B. Robinson
7. The Long and Winding Road: From the High Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors
Pedro R. Lowenstein and Maria G. Castro
8. Choline on the Move: Perspectives on the Molecular Physiology and Pharmacology of the Presynaptic Choline Transporter
Elizabeth A. Ennis and Randy D. Blakely
9. Still NAAG’ing after all these Years: The Continuing Pursuit of GCPII Inhibitors
James J. Vornov, Kristen R. Hollinger, Paul F. Jackson, Krystyna M. Wozniak, Mohamed H. Farah, Pavel Majer, Rana Rais and Barbara S. Slusher
10.  Ultimate Translation; Developing Therapeutics Targeting on N-methyl-D-aspartate Receptor
Guochuan Emil Tsai
11.  The Good and Bad Sides of NAAG
Pamela Khacho, Boyang Wang and Richard Bergeron
12.  The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment
Darrick T. Balu

Subject Areas: Neurosciences [PSAN], Pharmacology [MMG], Physiological & neuro-psychology, biopsychology [JMM]